Articles

  • 2 months ago | breakingcancernews.com | Mali R. Schantz-Feld

    A new test called PAC-MANN, being researched at Oregon Health & Science University (OHSU), is hoping to take a bite out of the time and costs of detecting pancreatic cancer. The study published February 12, 2025 in the journal Science Translational Medicine notes that “pancreatic ductal adenocarcinoma (PDAC) is among the top causes of cancer-related death.

  • 2 months ago | breakingcancernews.com | Mali R. Schantz-Feld

    When Marisol Gallagher got frustrated with taking antibiotics for her diverticulitis, just after her 50th birthday in the summer of 2013, she decided to undergo a colon resection surgery. When abdominal surgery discovered a large cyst on her right ovary, Gallagher, who was a nurse for more than 40 years, had a hunch that her symptoms may be ovarian cancer.

  • Dec 24, 2024 | breakingcancernews.com | Mali R. Schantz-Feld

    People with advanced or metastatic melanoma and other solid tumors may soon have more options for treatment. In July 2024, Obsidian Therapeutics, Inc.  earned FDA Fast Track Designation for its treatment for metastatic or locally advanced melanoma that is resistant to or has relapsed after PD-1/PD-L1–based immune checkpoint inhibitors. OBX-115 is a novel engineered tumor-derived autologous T cell immunotherapy. “Immune checkpoints” prevent an immune response from destroying healthy cells.

  • Dec 10, 2024 | breakingcancernews.com | Mali R. Schantz-Feld

    Most dentists screen for oral cancer during routine checkups. They typically do a visual examination for white patches, sores, or lumps on the cheek lining, floor and roof of the mouth, gums, lips, tongue, and tonsils. Treatments for oral cancer, using special dyes or fluorescent light, have improved over time but often the challenge is detecting oral cancer early, before it has a chance to grow or spread.

  • May 7, 2024 | breakingcancernews.com | Mali R. Schantz-Feld

    Registered nurse, Vicki Jarvis, worked for years at Tampa General Hospital — in risk management, information technology, and medical records. She was nearing retirement, and at the end of 2017, her health care experience refocused on herself as she was diagnosed with Stage 3 HER2+ positive, an estrogen-related breast cancer. This news set Jarvis on a treatment journey that is now on a positive path with an oral medication called Verzenio® (abemaciclib).

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →